The Nutshell

» genetics & genomics, funding and disease/medicine

Daily News Roundup

Most Recent

image: Zika Update

Zika Update

By | September 7, 2016

Virus’s genome to aid in diagnoses; bees caught in crossfire of mosquito sprays; Zika spreads in Asia; US Congress revisits Zika funding

1 Comment

image: Newly Discovered Virus Has Multi-Part Genome

Newly Discovered Virus Has Multi-Part Genome

By | August 26, 2016

A “multicomponent” virus isolated from mosquitoes infects in stages and reassembles once the pieces are inside the host.

3 Comments

image: UK Government Guarantees EU Funding

UK Government Guarantees EU Funding

By | August 16, 2016

British scientists will continue to receive grants from the European Union, including its flagship program Horizon 2020.

0 Comments

image: Polio Reemerges in Nigeria

Polio Reemerges in Nigeria

By | August 15, 2016

Prior to last week’s announcement of newly confirmed cases, the country had been polio-free for two years.

1 Comment

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: NIH Reveals Plan to Fund Human-Animal Chimeras

NIH Reveals Plan to Fund Human-Animal Chimeras

By | August 4, 2016

The public gets to weigh in before the US government lifts its ban on such research.

0 Comments

Access to data from thousands of genotyping customers helped scientists detect novel associations with the disorder across the genome.

2 Comments

image: Wolf Species Are Part Coyote

Wolf Species Are Part Coyote

By | July 28, 2016

Genomic analysis reveals wolves and coyotes have hybridized, potentially complicating wolves' protection under the US Endangered Species Act.

0 Comments

image: Additional #IceBucketChallenge Payoffs

Additional #IceBucketChallenge Payoffs

By | July 28, 2016

Researchers identify a new ALS-associated gene thanks to funds generated by the social media challenge that went viral in summer 2014.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech